MAPT and Alzheimer disease: TREM2 microglia has been intensively investigated in response to amyloid β (Aβ) and tau [40, 42, 43], while recent studies revealed distinct responses of cortical and subcortical TREM2 microglia to the Alzheimer’s disease (AD) pathology [44].